We specialize in hard to find items
All Categories
Soft Tissue and Bone Tumours: WHO Classification of Tumours (Medicine)
Share Tweet
*Price and Stocks may change without prior notice
*Packaging of actual item may differ from photo shown
- Electrical items MAY be 110 volts.
- 7 Day Return Policy
- All products are genuine and original
- Cash On Delivery/Cash Upon Pickup Available
Soft Tissue and Bone Tumours: WHO Classification of Features
-
brand: World Health Organization
-
WHO classification of tumours of soft tissue and bone tumours: 3 (World Health Organization Classification of Tumours)
About Soft Tissue And Bone Tumours: WHO Classification Of
PLEASE NOTE: Text has been accidentally deleted frompage 54 of this book. Please refer to the corrigenda (PDF file) posted on the Stylus Publishing web site or email [email protected] for an updated, printable page. ****When not purchasing directly from the official sales agents of the WHO, especially at online bookshops, please note that there have been issues with counterfeited copies. Buy only from known sellers and if there are quality issues, please contact the seller for a refund.***** Soft Tissue and Bone Tumours is the third volume in the 5th edition ofthe WHO series on the classification of human tumors. This series (also knownas the WHO Blue Books) is regarded as the gold standard for the diagnosis oftumors and comprises a unique synthesis of histopathological diagnosis with digital and molecular pathology. These authoritative and concise referencebooks provide indispensable international standards for anyone involved in thecare of patients with cancer or in cancer research, underpinning individualpatient treatment as well as research into all aspects of cancer causation,prevention, therapy, and education. This volume will be of particular interest to pathologists, oncologists,surgeons, and epidemiologists who manage or research soft tissue and bonetumors. Sections are included on all recognized neoplasms of the soft tissueand bone, as well as on genetic tumor syndromes affecting these sites. Sincethe previous edition, there have been changes based on recent molecular andgenetic information, with impact on clinical practice.
